NCT04524858View on ClinicalTrials.gov

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

February 25, 2021

Study Completion Date

February 25, 2021

Conditions
Cryopyrin-Associated Periodic Syndrome
Interventions
DRUG

ATI-450

Oral, small molecule MK2 inhibitor

Trial Locations (2)

92123

Aclaris Investigational Site, San Diego

94116

Aclaris Investigational Site, San Francisco

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY